Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria, 1997-2008

International Journal of Antimicrobial Agents

Volumn 36, Issue 1, 2010, Pages 24-27

  Hoenigl, M ^a   Fussi, P ^a   Feierl, G ^a   Wagner Eibel, U ^a   Leitner, E ^a   Masoud, L ^a   Zarfel, G ^a   Marth, E ^a   Grisold, A J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Austria; Penicillin; Resistance; Streptococcus pneumoniae; Surveillance

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRIA; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 77953020779     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.001     Document Type: Article

References (32)

1. Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992, 14:801-807.
2. EARSS Annual Report 2006. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2007. [accessed 15 November 2009]. http://www.rivm.nl/earss/Images/EARSS%202006%20Def_tcm61-44176.pdf.
3. Fletcher M.A., Laufer D.S., McIntosh E.D.G., Cimino C., Malinoski F.J. Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?. Int J Clin Pract 2006, 60:450-456.
4. Sjöström K., Spindler C., Ortqvist A., Kalin M., Sandgren A., Kühlmann-Berenzon S., et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006, 42:451-459.
5. Metz-Gercek S., Mittermayer H. The European surveillance activities EARSS and ESAC in the context of ABS International. Wien Klin Wochenschr 2008, 120:264-267.
6. Appelbaum P.C. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002, 34:1613-1620.
7. Arbique J.C., Poyart C., Trieu-Cuot P., Quesne G., Carvalho Mda G., Steigerwalt A.G., et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004, 42:4686-4696.
8. Gardam M.A., Miller M.A. Optochin revisited: defining the optimal type of blood agar for presumptive identification of Streptococcus pneumoniae. J Clin Microbiol 1998, 36:833-834.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
10. Pihlajamäki M., Jalava J., Huovinen P., Kotilainen P. Antimicrobial resistance of invasive pneumococci in Finland 1999-2000. Antimicrob Agents Chemother 2003, 47:1832-1835. Finnish Study Group for Antimicrobial Resistance.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
12. Jenkins S.G., Brown S.D., Farrell D.J. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US years 1-4. Ann Clin Microbiol Antimicrob 2008, 7:1.
13. Low D.E. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Clin Infect Dis 2005, 41:228-233.
14. Shin J.H., Jung H.J., Kim H.R., Jeong J., Jeong S.H., Kim S., et al. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrob Agents Chemother 2007, 51:2625-2627.
15. EARSS Annual Report 2007. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2008. [accessed 18 November 2009]. http://www.rivm.nl/earss/Images/EARSS%202007_FINAL_tcm61-55933.pdf.
16. EARSS Annual Report 2008. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2009. [accessed 11 December 2009]. http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf.
17. Buxbaum A., Forsthuber S., Graninger W., Georgopoulos A. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria. J Antimicrob Chemother 2004, 54:247-250.
18. Metz-Gercek S., Maieron A., Strauss R., Wieninger P., Apfalter P., Mittermayer H. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis 2009, 9:61.
19. García-Suárez M., Villaverde R., Caldevilla A.F., Méndez F.J., Vázquez F. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococcal isolates in Asturias, Spain. Jpn J Infect Dis 2006, 59:299-305.
20. Lambertsen L.M., Harboe Z.B., Konradsen H.B., Christensen J.B., Hammerum A.M. Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates. Int J Antimicrob Agents 2010, 35:72-75.
21. Greenberg D., Givon-Lavi N., Sharf A.Z., Vardy D., Dagan R. The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis 2008, 27:776-782.
22. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001, 45:1721-1729.
23. Marchese A., Tonoli E., Balistreri G., Debbia E., Schito G.C. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. Microb Drug Resist 2000, 6:163-170.
24. pC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J Antimicrob Chemother 2001, 47:863-866.
25. Riedel S., Beekmann E., Heilmann P., Richter S.S., Gardia-deLomas J., Ferech M., et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007, 26:485-490.
26. Mittermayer H., Jebelean C., Binder L., Haditsch M., Watschinger R. Antibiotic susceptibility of pneumococci isolated in Austria over a four-year period. Eur J Clin Microbiol Infect Dis 1996, 15:817-820.
27. Canton R., Morosini M., Enright M.C., Morrissey I. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother 2003, 52:944-952.
28. Garcia-Rey C., Louie A., Deziel M., Gumbo T. Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Microbiol Infect 2006, 12:55-66.
29. Adam H.J., Schurek K.N., Nichol K.A., Hoban C.J., Baudry T.J., Laing N.M., et al. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae in Canada, 1997 to 2005. Antimicrob Agents Chemother 2007, 51:198-207.
30. Reinert R.R., Reinert S., Van der Linden M., Cil M.Y., Al-Lahham A., Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005, 49:2903-2913.
31. Goldsmith C.E., Moore J.E., Murphy P.G., Ambler J.E. Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. J Antimicrob Chemother 1998, 41:420-421.
32. Appelbaum P.C., Gillespie S.H., Burley C.J., Tillotson G.S. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Int J Antimicrob Agents 2004, 23:533-546.